RBC Capital sets EUR 25 target for Philips stock

Published on 10/13/2026 at 09:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached EUR 4.36 billion, up 4.00 percent comparably. Philips stock costs EUR 22.30 on October 13, 2026 versus EUR 22.14.

Key points in brief

RBC Capital set a EUR 25.00 price target and maintained a Hold rating for Philips on October 12, 2026.
Philips formed a 12-member Sonicare Global Clinical Advisory Board on October 8, 2026.
Second-quarter 2026 revenue reached EUR 4.36 billion, with comparable sales growth of 4.00 percent.
Philips stock was EUR 22.30 at Lang & Schwarz on October 13, 2026, while market capitalization was EUR 21.9 billion.

Börsen-Editorial mit AEX-Kurstafeln und Händlern auf geschäftigem Handelsparkett — Koninklijke Philips N.V. (NL0000009538) illustriert Börsen-Editorial mit AEX-Kurstafeln und Händlern auf geschäftigem Amsterdamer Handelsparkett, Illustration mit AI erstellt.

Philips (ISIN NL0000009538) was trading at EUR 22.30 at Lang & Schwarz on October 13, 2026 at 9:38 a.m. CEST. RBC Capital maintained a Hold rating and set a EUR 25.00 price target for Koninklijke Philips N.V. on October 12, 2026, according to Markets Insider.

RBC target leaves limited upside

The EUR 25.00 target stands 12.11 percent above the Lang & Schwarz price of EUR 22.30. RBC's Hold view also sits below the EUR 23.84 average target cited in the same October 12 report, giving investors a concrete measure of the cautious analyst stance.

The target is close to the market's recent trading area rather than a high-growth revaluation. Philips stock remains 19.11 percent below its 52-week high of EUR 27.57 and 6.60 percent above its 52-week low of EUR 20.92, based on the October 13 market snapshot.

Three dated Philips developments

On July 28, 2026, Philips reported second-quarter revenue of EUR 4.36 billion and comparable sales growth of 4.00 percent. De Belegger also reported adjusted EBITA of EUR 717.00 million and an adjusted EBITA margin of 16.40 percent for the quarter.

On September 16, 2026, Philips said Philips-led projects had won ITEA awards for AI-enabled healthcare innovation, according to the company's investor-relations chronology. On October 8, 2026, Philips announced a 12-member Global Clinical Advisory Board for Sonicare. The board is intended to guide product development, emerging-trend analysis and clinical exploration, according to Philips.

What does the margin mean?

The second-quarter adjusted EBITA margin of 16.40 percent included a US tariff refund, making the reported profitability figure less representative of recurring operations. The comparison matters because revenue grew 4.00 percent comparably while the one-off benefit supported margin performance, leaving order conversion and cash generation as key checks for the next report.

Philips stock stays below its high

At 9:38 a.m. CEST on October 13, 2026, Philips stock was trading at EUR 22.30 at Lang & Schwarz, plus 0.72 percent versus the Xetra close of October 12, 2026 at EUR 22.14. The stock therefore remained below the EUR 25.00 RBC target and the EUR 27.57 52-week high. The further course of trading is shown by the continuously updated real-time quote of Philips stock.